Work

NCI 8609: Multicenter Phase I Trial of PARP Inhibitor Veliparib with Carboplatin in Advanced Breast Cancer

Year: 2013

Type: article

Study design: Clinical Trial

Source: Annals of Oncology

DOI: 10.1093/annonc/mdt081.1

Authors: B. Ramaswamy, S. Geyer, M. Lustberg, R. Wesolowski, E. Andreopoulou, M. Knopp, M. Villalona, A. Chen, M. Grever, C. Shapiro

Institutions: The Ohio State University, Albert Einstein College of Medicine, National Cancer Institute

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2038811586

FWCI:

Cites:

Cited by:

Related to: 10